Expression and function of a recombinant endothelial nitric oxide synthase gene in porcine coronary arteries

Cardiovascular Research

Volumn 35, Issue 3, 1997, Pages 553-559

  Cable, David G ^a   O'Brien, Timothy ^a   Kullo, Iftikhar J ^a   Schwartz, Robert S ^a   Schaff, Hartzell V ^a   Pompili, Vincent J ^b  

^a MAYO CLINIC   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenoviral vector; Gene therapy; Nitric oxide synthase; Porcine coronary artery; Vasomotor function

Indexed keywords

NITRIC OXIDE SYNTHASE; RECOMBINANT PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; GENE EXPRESSION; GENE TRANSFER; GENETIC RECOMBINATION; NONHUMAN; PRIORITY JOURNAL; SWINE; VASCULAR ENDOTHELIUM; VASOMOTOR REFLEX;

ADENOVIRIDAE; ANALYSIS OF VARIANCE; ANIMALS; CALCIMYCIN; CORONARY DISEASE; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; IMMUNOHISTOCHEMISTRY; IONOPHORES; NITRIC OXIDE SYNTHASE; NITRITES; OMEGA-N-METHYLARGININE; SWINE; VASOCONSTRICTION;

EID: 0030729073     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00161-2     Document Type: Article

References (35)

1. Lama S., Mardsen P., Lie G.K.et al. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA. 89:1992;6348-6352.
2. Pollock J.S., Forstermann U., Mitchell J.A.et al. Purification and characterization of particulate endothelium derived relaxing factor synthase from cultured bovine and native bovine aortic endothelial cells. Proc Natl Acad Sci USA. 88:1992;10480-10488.
3. Bredt D., Synder S. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA. 87:1990;682-685.
4. Bredt D., Hwang P.M., Synder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 347:1990;768-770.
5. Hevel J., White K.A., Marletta M.A. Purification of the inducible murine macrophage nitric oxide synthase. J Biol Chem. 266:1991;22789-22791.
6. Lyons C.R., Orloff G.J., Cunningham J.M. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem. 267:1992;6370-6374.
7. Ignarro L.F., Buga G.M., Wood K.S.et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 84:1987;9265-9269.
8. Radomski M.W., Palmer R.M.J., Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol. 92:1987;181-187.
9. Radomski M.W., Palmer R.M.J., Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol. 92:1987;639-646.
10. Schafer A.I., Alexander R.W., Handin R.I. Inhibition of platelet function by organic nitrate vasodilators. Blood. 55:1980;649-654.
11. von der Leyen H.E., Gibbons G.H., Morishita R., Lewis N.P., Zhang L., Nakajima M., Kaneda Y., Cooke J.P., Dzau V.J. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA. 92(4):1995;1137-1141.
12. Schwartz R.S., Murphy J.C., Edwards W.D.et al. Restenosis after balloon angioplasty: a practical proliferative model in porcine coronary arteries. Circulation. 82:1990;2190-2200.
13. Graham F.L., Smiley J., Russell W.C., Nairn R. Characteristics of a human cell line transformed by human adenovirus type 5. J Gen Virol. 36:1977;59-74.
14. Jones N., Shenk T. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell. 17:1979;683-689.
15. Spector D.J., Samaniego L.A. Construction and isolation of recombinant adenovirus with gene replacements. Methods Mol Genet. 7:1995;31-44.
16. Volkert F.C., Young C.S. The genetic analysis of recombination using adenovirus overlapping terminal DNA fragments. Virology. 125:1983;175-193.
17. Felgner P.L. Particulate systems and polymers for in vitro and in vivo delivery of polynucleotides. Adv Drug Deliv Rev. 5:1990;163-187.
18. Sanes J.R., Rubenstein J.L.R., Nicolas J.F. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5:1986;3133-3142.
19. Misko T.P., Schilling R.J., Salvemini D.et al. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem. 214:1993;11-16.
20. Pearson P.J., Schaff H.V., Vanhoutte P.M. Acute impairment of endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries. Circ Res. 67:1990;385-393.
21. Iqbal A., Vanhoutte P.M. Flunarizine inhibits endothelium-dependent hypoxic facilitation in canine coronary arteries through an action on the vascular smooth muscle. Br J Pharmacol. 95:1988;789-794.
22. 2SO) and storage at -196 degrees C. Cryobiology. 31:1994;330-335.
23. Zhang F., Sowers J.R., Ram J.L.et al. Effects of pioglitazone on calcium channels in vascular smooth muscle. Hypertension. 24:1994;170-175.
24. Kobzik L., Bredt D.S., Lowenstein C.J.et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol. 9:1993;371-377.
25. Mannick J.B., Asano K., Izumi K.et al. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell. 79:1994;1137-1146.
26. Morris S.M. Jr., Billiar T.R. New insights into the regulation of inducible nitric oxide synthase. Am J Physiol. 266:1994;E829-E839.
27. Galler D.A., Nussler A.K., Di Silvio M.et al. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA. 90:1993;522-526.
28. Nussler A.K., Di Silvio M., Billiar T.R.et al. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med. 176:1992;261-264.
29. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem. 269:1994;4705-4708.
30. De Vera M.E., Shapiro R.A., Nussler A.K.et al. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci USA. 93:1996;1054-1059.
31. Chen AFY, O'Brein T, Tsutsui M et al. Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery. Circulation (in press).
32. Shimokawa H., Aarhus L.L., Vanhoutte P.M. Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Circ Res. 61:1987;256-270.
33. Evora P.R., Pearson P.J., Schaff H.V. Impaired endothelium-dependent relaxation after coronary reperfusion injury: evidence for G-protein dysfunction. Ann Thorac Surg. 57:1994;1550-1556.
34. Evora P.R., Pearson P.J., Schaff H.V. Oxygen radical-mediated vascular injury selectively inhibits receptor-dependent release of nitric oxide from canine coronary arteries. J Thorac Cardiovasc Surg. 107:1994;505-509.
35. Mehdi K., Wilensky R.L., Baek S.H., Trapnell B.C., March K.M. Efficient adenoviral-mediated perivascular gene transfer. J Am Coll Cardiol. 27(2):1996;164A.